Sun Pharma rallies 4% as Credit Suisse upgrades to outperform, sees 23% upside
Most Popular (6 hours)

Sugar falls on lower demand

- business-standard

Most Popular (24 hours)

Most Popular (a week)

RSS celebrates Makar Sakranti

- news.statetimes.in

moneycontrol.com
4 months ago

Sun Pharma rallies 4% as Credit Suisse upgrades to outperform, sees 23% upside

Key risks according to Credit Suisse are Halol resolution delay, Dadra Form 483, and Department of Justice (DOJ) penalty.

Read on the original site


Dear chief design officer

- business-standard

Surhoneyi is PAWA champ

- nagalandpost.com

Lack of professional ethics

- news.statetimes.in

Safety of girl child

- news.statetimes.in

Protect kids in war zones

- news.statetimes.in

Oldest music festival

- news.statetimes.in

Kartik and Malvika steal show

- business-standard

Vizhinjam Port CEO quits

- business-standard
Hashtags:   

Sun

 | 

Pharma

 | 

rallies

 | 

Credit

 | 

Suisse

 | 

upgrades

 | 

outperform

 | 

sees

 | 

23%

 |